Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
Showing 1–60 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
…ad and neck squamous cell carcinoma (HNSCC) patients undergoing immunotherapy, analyzing over 8 million cells. A comprehensive 52-antibody pa…
…ved spatial features enabled prediction of trastuzumab response.Immunotherapy (IO) response prediction: In the Histo-Miner CPI dataset,3 Hist…
…rent treatments including surgery, radiation, chemotherapy, and immunotherapy provide limited efficacy.2 Mesothelin (MSLN) is a tumor-associa…
…iling of the NSCLC TME reveals key prognostic markers linked to immunotherapy response. We present a scalable framework for spatial biomarker…
…imodal conventional therapies such as surgery, radiotherapy and chemotherapy have shown limited results in glioma patients. Over the last de…
…and (3) IFN-γ gene profiling for ambiguous cases—can streamline immunotherapy selection, enhance precision, and eliminate unnecessary spendin…
…Background CAR T-cell therapy has achieved remarkable responses in patients with relapsed/ref…
…rdal A. Model of patient-specific immune-enhanced organoids for immunotherapy screening: feasibility study. Annals of Surgical Oncology 2020;…
… predicting long-term outcomes in patients with NSCLC receiving curative-intent treatment. This highlights the importance of ctDNA as a prognostic marker…
…p=0.035), EBV DNA level (HR 1.743, 95%CI 1.252-2.426, p=0.001), locoregional therapy (HR 0.467, 95%CI 0.268-0.812, p=0.007), and rechallenge with an…
…py and have dismal prognosis. However, the mechanistic basis of immunotherapy resistance is unknownMethods Various orthogonal models of SMARC…
…ell lung cancer (NSCLC) lacking actionable genomic alterations, platinum doublet chemotherapy is the standard treatment following progression on dual ICI the…